M2a Macrophage-Dominant Microenvironment in Inflammation Attenuation and Wound Healing of Human Corneal Endothelial Cells
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.6.35 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Seung Hyeun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chung-Ang Ocular Surface Restoration via Immune-Inflammation Alleviation (CORIA) Laboratory, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Wound Healing, Macrophages, Endothelium, Corneal, Cellular Microenvironment. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Purpose
To investigate the anti-inflammatory and wound-healing effects of an M2a macrophage-dominant microenvironment on human corneal endothelial cells (HCECs) in vitro.
Methods
Two in vitro corneal endothelial inflammation models were developed: a lipopolysaccharide (LPS)-induced inflammation-only model and a dual inflammation-and-wound model. HCECs were co-cultured with M2a macrophages or treated with M1 macrophage-derived exosomes (M1-exo), M2a macrophage-derived exosomes (M2a-exo), or epidermal growth factor (EGF)-preconditioned M2a-derived exosomes (EGF-M2a-exo). Gene and protein expression of inflammatory markers was assessed, and HCEC proliferation was evaluated using cell growth curves.
Results
Scratch wounding alone did not induce significant inflammation in HCECs, whereas LPS stimulation combined with scratch wounding markedly increased inflammatory responses. In the inflammation-only model, co-culture with M2a macrophages or M2a-exo treatment significantly suppressed LPS-induced upregulation of IL6, IL1B, and ICAM1 at the mRNA level in HCECs and reduced IL-6 protein secretion. In the dual inflammation-and-wound model, M2a-exo showed limited efficacy, but EGF-M2a-exo significantly reduced inflammatory marker expression. Cell growth analysis revealed that M2a-exo treatment promoted faster HCEC proliferation compared to M1-exo treatment under non-inflammatory conditions, despite no significant differences in cell cycle-related genes. In LPS-stimulated HCECs, EGF-M2a-exo treatment restored proliferation to levels comparable with non-inflammatory controls by day 5.
Conclusions
An M2a macrophage-dominant microenvironment demonstrates anti-inflammatory and regenerative effects on inflamed HCECs. EGF preconditioning enhances these properties, suggesting a potential therapeutic approach for managing corneal endothelial inflammation and injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chung-Ang Ocular Surface Restoration via Immune-Inflammation Alleviation (CORIA) Laboratory, Seoul, Republic of Korea.
- Department of Ophthalmology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, Gyeonggi-do, Republic of Korea.
- Chung-Ang University Graduate School, Seoul, Republic of Korea.
- Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Ophthalmology, Chung-Ang University College of Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.
Zitieren
APA
Lee, S. H., Koh, A., Lee, S. J., Lee, H., & Kim, K. W. (2025). M2a Macrophage-Dominant Microenvironment in Inflammation Attenuation and Wound Healing of Human Corneal Endothelial Cells. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.6.35
Vancouver
Lee SH, Koh A, Lee SJ, Lee H, Kim KW. M2a Macrophage-Dominant Microenvironment in Inflammation Attenuation and Wound Healing of Human Corneal Endothelial Cells. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.6.35
BibTeX
@article{Lee2025,
author = {Lee, Seung Hyeun and Koh, Ahra and Lee, Soo Jin and Lee, Hun and Kim, Kyoung Woo},
title = {M2a Macrophage-Dominant Microenvironment in Inflammation Attenuation and Wound Healing of Human Corneal Endothelial Cells},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.6.35}
}
EUVIMED